AKR1C1 and non-small cell lung carcinoma: In this regard, our discovery of ALA as a direct natural inhibitor of AKR1C1 with selectivity in NCI-H460 cells provides a unique pharmacological candidate to inhibit cell proliferation and metastasis in NSCLC.